Literature DB >> 7507881

Immunohistochemical detection of granulocyte/macrophage colony-stimulating factor in Langerhans' cell histiocytosis.

J F Emile1, M Peuchmaur, S Fraitag, C Bodemer, N Brousse.   

Abstract

Granulocyte/macrophage-colony stimulating factor (GM-CSF) induces in vitro activation of Langerhans' cells. The association of GM-CSF and tumour necrosis factor alpha (TNF alpha) induces the differentiation of Langerhans' cells from CD34 positive haematopoietic progenitors. Intradermal administration of recombinant GM-CSF is associated with local accumulation of Langerhans' cells. We investigated the presence of GM-CSF in tissue samples of 10 patients with Langerhans' cell histiocytosis. Four patients had skin involvement, three had bone and three had diffuse disease. Eight normal skin samples were analysed as controls. Immunohistochemistry was performed on frozen tissue samples with two specific monoclonal antibodies directed against two different epitopes of GM-CSF. We detected GM-CSF in all the histiocytosis tissue samples. The GM-CSF was detected within the cytoplasm of all the tumoral Langerhans' cells. We did not find GM-CSF in any other cell type. These results suggest that GM-CSF may be implicated in the pathogenesis of Langerhans' cell histiocytosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507881     DOI: 10.1111/j.1365-2559.1993.tb01215.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

Review 1.  Adult pulmonary Langerhans' cell histiocytosis.

Authors:  A Tazi; P Soler; A J Hance
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

2.  Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells.

Authors:  E Brabencova; A Tazi; M Lorenzato; M Bonay; M Kambouchner; J F Emile; A J Hance; P Soler
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 3.  The histopathology of Langerhans cell histiocytosis.

Authors:  B E Favara; R Jaffe
Journal:  Br J Cancer Suppl       Date:  1994-09

4.  IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.

Authors:  Ichiro Murakami; Akira Morimoto; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Yasushi Horie; Kazuhiko Hayashi; Jean Gogusev; Francis Jaubert; Shinsaku Imashuku; Lamia Abd Al-Kadar; Katsuyoshi Takata; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2012-12-27       Impact factor: 4.064

5.  New insights into the molecular pathogenesis of langerhans cell histiocytosis.

Authors:  Francesca M Rizzo; Mauro Cives; Valeria Simone; Franco Silvestris
Journal:  Oncologist       Date:  2014-01-16

6.  Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.

Authors:  M Paulli; A C Feller; E Boveri; S Kindl; E Berti; R Rosso; H Merz; F Facchetti; C Gambini; F Bonetti
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells.

Authors:  J F Emile; S Fraitag; P Andry; M Leborgne; A Lellouch-Tubiana; N Brousse
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.